Fundación Ifarma Opposition, Cabotegravir/Rilpirivine Pediatric, (Nc2025/0004675)
No Annotations
Alert me when there are new annotations for this document
3 similar patent oppositions
-
Fundación Grupo Efecto Positivo opposition, Dolutegravir pediatric combination, (P20210101732 (AR122720A1))
Countries: Argentina Date: 2025
-
Fundación Grupo Efecto Positivo (FGEP) opposition, Dolutegravir pediatric dispersible tablet, (P20210101730 (AR122718A1) )
Countries: Argentina Date: 2025
-
Fundación Grupo Efecto Positivo (FGEP) opposition, Dolutegravir/Rilpivirine, (AR112213A1 (P20180101799) )
Countries: Argentina Date: 2025